These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety. Anil Yağcioğlu AE; Kivircik Akdede BB; Turgut TI; Tümüklü M; Yazici MK; Alptekin K; Ertuğrul A; Jayathilake K; Göğüş A; Tunca Z; Meltzer HY J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890 [TBL] [Abstract][Full Text] [Related]
5. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268 [TBL] [Abstract][Full Text] [Related]
6. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Lerner V; Libov I; Kotler M; Strous RD Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862 [TBL] [Abstract][Full Text] [Related]
7. Clozapine affects the pharmacokinetics of risperidone and inhibits its metabolism and P-glycoprotein-mediated transport in vivo and in vitro: A safety attention to antipsychotic polypharmacy with clozapine and risperidone. Liu X; Sun H; Zhang Y; Sun Y; Wang W; Xu L; Liu W Toxicol Appl Pharmacol; 2021 Jul; 422():115560. PubMed ID: 33957192 [TBL] [Abstract][Full Text] [Related]
8. Case studies of adjunctive agents in clozapine-resistant schizophrenic patients. Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Roukas DK; Christodoulou GN Clin Neuropharmacol; 2005; 28(1):50-3. PubMed ID: 15711437 [TBL] [Abstract][Full Text] [Related]
13. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group. Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. Zink M; Kuwilsky A; Krumm B; Dressing H J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423 [TBL] [Abstract][Full Text] [Related]
15. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients. Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740 [TBL] [Abstract][Full Text] [Related]
16. Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison. Schooler NR; Marder SR; Chengappa KN; Petrides G; Ames D; Wirshing WC; McMeniman M; Baker RW; Parepally H; Umbricht D; Kane JM J Clin Psychiatry; 2016 May; 77(5):628-34. PubMed ID: 27035871 [TBL] [Abstract][Full Text] [Related]
17. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach. Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023 [TBL] [Abstract][Full Text] [Related]
18. Toxic interaction between risperidone and clozapine: a case report. Kontaxakis VP; Havaki-Kontaxaki BJ; Stamouli SS; Christodoulou GN Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):407-9. PubMed ID: 11817521 [TBL] [Abstract][Full Text] [Related]
19. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748 [TBL] [Abstract][Full Text] [Related]
20. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia. Li H; Rui Q; Ning X; Xu H; Gu N Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]